ロード中...

Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review

Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity in individuals with obesity. Although multiple pharmacotherapeutics are in development, currently there are limited strategies specifically targeting NAFLD. This systematic review summarizes the existing literature on hepatic effects...

詳細記述

保存先:
書誌詳細
出版年:Front Endocrinol (Lausanne)
主要な著者: Pan, Chelsea S., Stanley, Takara L.
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046622/
https://ncbi.nlm.nih.gov/pubmed/32153507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00070
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!